fda import alert glp-1 semaglutide tirzepatide green list FDA's cracks down on illegal imported drug ingredients FDA sends warning letter after

Just as important, their arrival coincided with a cultural shift: obesity was increasingly recognized as a chronic disease rather than a personal failing

The company said a "strategic shift" means it will now focus on "an increasing variety of FDA-approved GLP-1s," making compounded semaglutide available only to patients whose physician determines that it is "clinically necessary." Under US regulations, compounders can only provide in-patent medicines that are in short supply which no longer applies to semaglutide or in niche applications to provide personalised formulations not available from the original manufacturer

Some patients with Hashimoto's disease may ask about dietary supplements such as selenium

The goal is to protect your muscle, fuel your body, and make the process sustainable